Skip to main content
Midas Edge

Camp4 Therapeutics Corp

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

CAMP$4.69+15.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

TABLE OF CONTENTS

Page
Part I3
Item 1. Business7
Item 1A. Risk Factors47
Item 1B. Unresolved Staff Comments104
Item 1C. Cybersecurity104
Item 2. Properties105
Item 3. Legal Proceedings105
Item 4. Mine Safety Disclosures105
Part II106
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities106
Item 6. Reserved106
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations107
Item 7A. Quantitative and Qualitative Disclosures About Market Risk119
Item 8. Financial Statements120
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures146
Item 9A. Controls and Procedures146
Item 9B. Other Information146
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections146
Part III
Item 10. Directors, Executive Officers and Corporate Governance147
Item 11. Executive Compensation147
Item 12. Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters147
Item 13. Certain Relationships and Related Transactions, and Director Independence147
Item 14. Principal Accounting Fees and Services147
Part IV148
Item 15. Exhibits, Financial Statement Schedules148
Signatures151
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.